The mRNA technology company Moderna (Nasdaq:MRNA) said it is planning to charge between $110 to $130 for COVID-19 vaccine doses in the U.S. once private market sales begin. Pfizer (NYSE:PFE) had previously announced that it was targeting the same range for COVID-19 vaccine doses. Moderna CEO Stéphane Bancel said the company is now in discussions with hospitals, pharmacies…
Multiple COVID-19 vaccine doses associated with lower symptom burden
A study of essential and frontline workers infected with COVID-19 found that recent vaccination was associated with a variety of benefits. In particular, the workers who had received two or three mRNA COVID-19 vaccine doses had lower viral loads than the unvaccinated. They also had fewer fever and chill symptoms and were less likely to…